Article PDF
References
Bron AJ and Brown NAP : The pathology of cataract. In preparation.
Pongor S, Ulrick PC, Bensath FA, Cerami A . Proc Natl Acad Sci 1984, 81: 2684–7.
Giblin FJ, Schrimscher, Reddam JR, Dziedzic D, Reddy VN : The relative roles of catalase and the glutathione redox cycle in detoxification of H2O2 by the lens. Invest Ophthalmol Vis Sci 1987, 23: 190 (Abstr 4).
Garadi R, Lou M, Whitney A : Ascorbic acid protection against oxidative damage to lens Na+ K+ ATPase and transport systems. Invest Ophthalmol Vis sci (Suppl) 1986, 27: 277 (Abstr 59).
Fukushi S and Susuki T : Double blind test of Phacolysin effect on senile cataract. Ganka Rinsho Iho 1977, 71: 303–6.
Hightower K : Membrane-SH groups and permeability. Invest Ophthalmol Vis Sci (Suppl) 1986, 27, 8 (Abstr 9).
Datiles M, Fukui H, Kinoshita JH : Galactose cataract prevention with Sorbinil, an aldose reductase inhibitor: a light microscope study. Invest Ophthalmol Vis Sci 1982, 22: 174–9.
Fukushi S, Merola LO, Kinoshita JH : Altering the course of cataracts in diabetic rats. Invest Ophthalmol Vis Sci 1980, 19: 313–15.
Hu C, Merolo LO, Kuwabara T, Kinoshita JH : Invest Ophthalmol Vis Sci 1984, 25: 603–5.
Stribling D, Mirrlees DJ, Harrison HE, Earl DCN : Properties of IC128,436 a novel aldose reductase inhibitor and its effect on diabetic complications in the rat. Metabolism 1985, 34: 336–44.
Ross WM, Creighton MO, Trevithick JR : Modelling cortical cataractogenesis: 3. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Canad J Ophthalmol 1982, 17: 61–6.
Crompton M, Rixon KC, Harding JJ : Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities. In-vitro. A possible mechanism by which aspirin could prevent cataract. Exp Eye Res 1985, 40: 297–311.
Lewis BS, Rixon KK, Harding JJ : Bendazac prevents cyanate binding to soluble lens proteins and cyanate induced phase separation opacities in vitro: A possible mechanism by which Bendazac could delay cataract. Exp Eye Res 1986, 43: 973–9.
Blondin J, Baragi V, Schwartz ER, Sadowski JA, Taylor A : Dietary vitamin C prevents eye lens protein damage. Invest Ophthalmol Vis Sci (Suppl) 1986, 27: 9 (Abstr 14) .
Miyata A : Studies on the experimental dimtrophenol cataract. Acta Soc Ophthalmol Jpn 1968, 72: 2307–24.
Von Sallman L : Further efforts to influence x-ray cataract by chemical agents. Arch Ophthalmol 1952, 48: 276–91.
Pirie A and Lajtha LG : Possible mechanism of cysteine protection against radiation cataract. Nature 1959, 184: 1125–7.
Straub W, Graul EH, Ruther W et al.: Untersuchungen uber die Wirkung strahlenschutzender Substanzen am vorderer Augenabschnitt des Kaninchens nach der Einwirkung schneller Neutronen. Albrecht von Graefes Arch Ophthalmol 1966, 169: 1–11.
Sedlovets IF, Kozlov UA, Popov VV : Protection of the lens of mice against ionizing radiation with mercamine disulfide. Nach Kokl Vyssh Shk Biol Nauki 1967, 10: 67–70.
Hanna C and O'Brien JE : Effect on AET on X-ray radiation cataracts. Arch Int Pharmacodyn 1963, 142: 198–205.
Fedorenko BS, Kabachenko AN, Vainsthein et al.: Effect of taurine and vita-iodurol on the incidence of experimental radiation induced catar- acts. Vestn Oftalmol 1978a, 6: 67–9.
Fedorenko BS, Kabachenko AN, Jarcev EI et al.: Der Einfluss von Taurin auf die Dynamik der Entwicklung experimenteller Katarakte bei Tieren. Radiobiol Radiother 1978b, 19: 452–8.
Vodovozov AM and Glotova NM : Results of treating senile cataracts with taurine. Vestn Oftalmol 1981, 2: 44–5.
Kador PF : Overview of the current attempts toward the medical treatment of cataract. Ophthalmology 1983, 90: 352–64.
Weigein E and Hockwin O : Bericht ueber eine zufalls verteilte kontrolliert klinische Studie mit Phakan/Phakolen. Klin monatsbl Augenheilkd (In press).
Ichikawa H, Imaizumi K, Tazawa et al.: Effect of Tiopronin on senile cataracts. Ophthalmologica 1980, 180: 293–8.
Murata T : The effect of I-hydroxy-5-oxo-5H-pyrido (3, 2, ) phenoxazine-3-carboxylic acid (Catalin) on senile cataracts. Folia Ophthalmol Jpn 1980, 31: 1217–22.
Ogino S : Studies on the metabolism of crystalline lens. Acta Soc Ophthalmol Jpn 1955, 59: 666–710.
MacLean HA : A controlled trial of Catalin in senile cortical cataract. Concilium Ophthalmologicum 23rd, 1978. Kyoto (1979) 2: 1357–61.
Bonomi L, Marchini G, de Franco I, Perfetti S, de Gregorio M : Bendazac lysine salt in treatment of cataracts: A controlled study. Therapeutic Research 1983, 33: 768–82.
Mannucci LL, Doro D, Angi MR et al.: Treatment of presenile and senile cataract. Clinical evaluation of Bendazac lysine by means of a double-blind multicentre study. Boll di Oculistica 1983, 62: 87–94.
Testa M, Iuliano G, de Gregorio M, Pioggia M : A controlled clinical study of Bendzac lysine salt treatment in senile cataract. Acta Therapeutica 1983, 10: 177–90.
Cvintal T and Violante A : Double masked clinical trial of bendazac-lysine in senile patients. 25th International Congress of Ophthalmology, Rome, May 1986. (In press.)
Harding JJ and van Heyningen R : Epidemiology and risk factors for cataract. Eye 1987, 1: 537–541.
Brownlee M and Cerami A : The biochemistry of the complications of diabetes mellitus. Ann Rev Biochem 1981, 50: 385–432.
Brown NAP, Bron AJ, Ayliffe W, Sparrow J, Hill AR : The objective assessment of cataract. Eye 1987, 1: 234–46.
Author information
Authors and Affiliations
Additional information
Presented at the Annual Congress of the Ophthalmological Society of the United Kingdom, April 1987.
Rights and permissions
About this article
Cite this article
Bron, A., Brown, N., Sparrow, J. et al. Medical treatment of cataract. Eye 1, 542–550 (1987). https://doi.org/10.1038/eye.1987.83
Issue Date:
DOI: https://doi.org/10.1038/eye.1987.83
This article is cited by
-
The transparency of the lens: a comparison between diabetic and non-diabetic patients
International Ophthalmology (1990)
-
Clinical and physical measurements of the cataractous lens
Documenta Ophthalmologica (1990)